Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- Adult liver transplantation in Johannesburg, South Africa (2004 - 2016): Balancing good outcomes, constrained resources and limited donors.
- Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis.
- Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
- POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.
- Neuromuscular manifestations of primary biliary cholangitis: two case reports and literature review.
- Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.
- Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.
- Role of Biologics in the Development of Autoimmune Hepatitis: A Review.
- A Rare Tumor in the Common Bile Duct: A Case Report.
- Continuing Medical Education Questions: January 2019.
- Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
- Autoimmune Hepatitis with Concomitant Idiopathic Thrombocytopenic Purpura Diagnosed by Transjugular Liver Biopsy.
- Autoimmune hepatitis: Appraisal of current treatment guidelines.
- [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
- NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter.
- Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
- Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis.
- Current therapies and novel approaches for biliary diseases.
- The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK Signaling.
- Chloroquine Is Effective for Maintenance of Remission in Autoimmune Hepatitis: Controlled, Double-Blind, Randomized Trial.
- [The gut microbiome is important in chronic liver disease].
- Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
- [Study the role of lysosome-associated membrane protein type 2A for immune-mediated liver injury of primary biliary cholangitis].
- Rate of Spleen Length Progression is a Marker of Outcome in Patients with Primary Sclerosing Cholangitis.
- Pregnancy and Autoimmune Hepatitis: Presentation and Outcomes.
- Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.
- Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma.
- Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies.
- [A 28-Week-Pregnant Woman at Twenty Years of Age, Who Had Been Hospitalized with Jaundice].
- Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
- Liver damage related to immune checkpoint inhibitors.
- Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease.
- Beaded bile ducts in primary sclerosing cholangitis.
- Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis.
- GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump.
- The genetics of primary biliary cholangitis.
- Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis.
- Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs.
- Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases.
- Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.
- Acute onset of autoimmune hepatitis with sinusoidal and central vein endotheliitis, and marked involvement of activated dendritic cells: A case report.
- Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response.
- Editorial: deciding when to intervene in primary sclerosing cholangitis.
- Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis.
- [PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA].
- Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis.
- Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
- High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease.
- Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database.
- Coronary flow reserve is an innovative tool for the early detection of cardiovascular dysfunction in primary biliary cholangitis patients.
- Autoimmune hepatitis: Is the autoimmunity in the family?
- Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study.
- Clinical practice guidelines for IgG4-related sclerosing cholangitis.
- Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study.
- Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
- Apixaban-induced liver injury.
- Extrahepatic Autoimmune Diseases are Prevalent in Autoimmune Hepatitis Patients and Their First-Degree Relatives: Survey Study.
- Recent advances in IgG4-related disease, autoimmune pancreatitis and sclerosing cholangitis.
- Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
- Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease.
- Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile.
- Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.
- Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.
- Pruritus is Common and Under-treated in Patients with Primary Biliary Cholangitis in the United Kingdom.
- Frequency, Risk Factors, and Outcome of Gallbladder Polyps in Patients With Primary Sclerosing Cholangitis: A Case-Control Study.
- Interference with the lower gut-liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis.
- Platelet-Derived Growth Factor-D Enables Liver Myofibroblasts to Promote Tumor Lymphangiogenesis in Cholangiocarcinoma.
- Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease.
- Rare case of idiopathic sclerosing cholangitis, which was difficult to distinguish from cholangiocarcinoma: A case report.
- Primary biliary cholangitis and its association with other autoimmune diseases in a Mexican cohort.
- Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans.
- The metabolic signature of Primary Biliary Cholangitis and its comparison with Coeliac Disease.
- Use of Obeticholic Acid in Patients With Primary Biliary Cholangitis.
- No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
- NFKB1 and MANBA confer disease-susceptibility to primary biliary cholangitis via independent putative primary functional variants.
- LPAC syndrome: An uncommon etiology of intrahepatic cholelithiasis.
- Patient Group Input Submissions: Obeticholic Acid (Ocaliva): (Intercept Pharma Canada, Inc.): Indication: For the treatment of primary biliary cholangitis
- Pharmacoeconomic Review Report: Obeticholic Acid (Ocaliva): (Intercept Pharma Canada, Inc.): Indication: For the treatment of primary biliary cholangitis
- CADTH Canadian Drug Expert Committee Recommendation: Obeticholic Acid (Ocaliva — Intercept Pharmaceuticals Canada): Indication: Primary biliary cholangitis
- Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.
- Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.
- Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
- Lipoprotein-X fifty years after its original discovery.
- Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine.
- [Research progress on systemic lupus erythematosus overlapping organ-specific autoimmune diseases].
- The immunobiology of female predominance in primary biliary cholangitis.
- Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis.
- Subacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review.
- Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease.
- Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis.
- Acute Liver Failure.
- Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis.
- Differential characteristics in drug-induced autoimmune hepatitis.
- Non-alcoholic fatty liver disease in patients with autoimmune hepatitis.
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.
- Association Between Black Race and Presentation and Liver-related Outcomes of Patients With Autoimmune Hepatitis.
- Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitis.
- Xanthomas and xantelasmas in primary biliary cholangitis.
- [PAPA syndrome with Crohn's disease and primary sclerosing cholangitis/autoimmune hepatitis overlap syndrome].
- The More, the Better? Predicting Prognosis in Primary Biliary Cholangitis.
- Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review.
- Grand Round: Autoimmune Hepatitis.
- Linear IgA Bullous Dermatosis Preceding the Diagnosis of Primary Sclerosing Cholangitis and Ulcerative Colitis: A Case Report.
- Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
- Morning Bright Light Treatment for Sleep-Wake Disturbances in Primary Biliary Cholangitis: A Pilot Study.
- Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis.
- Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.
- Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals.
- Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
- Coronary flow reserve in patients with primary biliary cholangitis.
- Liver toxicity in the era of immune checkpoint inhibitors: A practical approach.
- Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
- Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis.
- Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells.
- High Seroprevalence of anti-Hepatitis E antibodies in Austrian patients with Autoimmune Hepatitis.
- Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
- [Radiologic diagnosis of the gallbladder and bile ducts - part 2 : Acute and chronic cholecystitis, primary sclerosing cholangitis (PSC), benign and malignant masses of the biliary system].
- Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance.
- Diagnosis and Management of Primary Biliary Cholangitis.
- Initial presentation determines clinical entity in patients with anti-centromere antibody positivity.
- False negative and false positive rates in common bile duct brushing cytology, a single center experience.
- Does colectomy affect the progression of primary sclerosing cholangitis? A systematic review and meta-analysis.
- Autoimmune Liver Diseases in Children.
- Prognostic models in primary biliary cholangitis.
- Effect of NGM282, a FGF19 analogue, in Primary Sclerosing Cholangitis: a Multicentre, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
- Isolated renal mucormycosis in a patient with Idiopathic CD4 lymphocytopenia.
- FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.
- Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
- H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α+ Periportal Hepatocytes but Not Cytokeratin 19+ Cholangiocytes in Cholestatic Livers.
- Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune Hepatitis.
- The epidermal growth factor receptor ligand amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis.
- Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature.
- Novel therapeutic targets in autoimmune hepatitis.
- Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.
- Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in patients with Inflammatory Bowel Disease.
- Animal models of cholestasis: An update on inflammatory cholangiopathies.
- De novo autoimmune hepatitis -is this different in adults compared to children?
- Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score.
- Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
- Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis.
- Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis.
- Etiopathogenesis of autoimmune hepatitis.
- [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
- Comorbidity of localized scleroderma and primary biliary cholangitis.
- Individual probe based confocal laser endomicroscopy criteria in the analysis of indeterminate biliary strictures.
- Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.
- Autoimmune Hepatitis in Pregnancy: Hematological Perturbation and Management Dilemma. A Case Report.
- High serum sCD40 and a distinct colonic T-cell profile in ulcerative colitis associated with primary sclerosing cholangitis.
- Clinical and histopathological features of immunoglobulin G4-associated autoimmune hepatitis in children.
- Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis (PBC) in Young patients: Analysis of the United Network for Organ Sharing Database.
- Recurrent and de novo autoimmune hepatitis.
- Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
- [Gut-liver axis: How intestinal bacteria affect the liver].
- The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
- Autoimmune sclerosing cholangitis: Evidence and open questions.
- Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: a single center follow-up study from China.
- Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
- Clinical presentation of autoimmune hepatitis in Pakistani children.
- Acute Liver Failure due to Disseminated Varicella Zoster Infection.
- Effects of liver transplantation on health-related quality of life in patients with primary biliary cholangitis (PBC).
- Extrahepatic autoimmunity in autoimmune liver disease.
- Role of TGR5 (GPBAR1) in Liver Disease.
- ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
- [Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial].
- Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis.
- Case Report: Acute Hepatitis E in a Pediatric Traveler Presenting with Features of Autoimmune Hepatitis: A Diagnostic and Therapeutic Challenge.
- Acute severe hepatitis with alemtuzumab and rechallenge after a year.
- Juvenile autoimmune hepatitis: A comprehensive review.
- Risk stratification and prognostic modelling in primary biliary cholangitis.
- Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.
- Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC).
- Primary biliary cholangitis and bone disease.
- Variant syndromes of primary biliary cholangitis.
- PBC and related extrahepatic diseases.
- Symptoms of PBC - Pathophysiology and management.
- Evolution of our understanding of PBC.
- Is PBC a viral infectious disease?
- Pathophysiology of primary biliary cholangitis.
- Geoepidemiology and (epi-)genetics in primary biliary cholangitis.
- PBC-transplantation and disease recurrence.
- Preface - Primary Biliary Cholangitis.
- Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant.
- Unique patterns of glycosylation in IgG4-related disease and primary sclerosing cholangitis.
- Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis.
- Esophageal Ulcers in Primary Biliary Cholangitis: A Rare Cause of Hematemesis in the Setting of Portal Hypertension and Esophageal Varices.
- Gut microbiota translocation promotes autoimmune cholangitis.
- Liver diseases in the elderly.
- A Histologically Proven Case of Autoimmune Hepatitis with Eosinophilic Fasciitis.
- Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
- Risk stratification and treatment of primary biliary cholangitis.
- High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy.
- Autoimmune liver disease serology in acute hepatitis E virus infection.
- In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response.
- Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis.
- Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.